AUTOLUS THERAPEUTICS PLC (AUTL)

Every figure this model derived for AUTL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 7,124,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 201,630,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 336,091,000 AssetsCurrent 2026-06-30
current liabilities 68,790,000 LiabilitiesCurrent 2026-06-30
equity 74,839,000 StockholdersEquity 2026-06-30
interest expense 41,806,000 InterestExpense 2026-06-30
ocf -225,608,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 117,390,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 15,438,000 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up AUTL on one particular measure came for.

RatioValue
cash operating margin-190.31
current ratio4.89
current ratio reported4.89
dilution pct4.31
ev owner earnings-1.69
ev sales3.58
fcf margin-198.26
growth cv1.18
interest cover-5.92
operating margin-210.78
owner earnings margin-211.41
revenue growth292.16
revenue growth per share275.98
rule of 4081.38
sbc pct revenue13.15

What to be careful about

What this model itself distrusts about AUTL's figures. Written by the derivation as it ran, not added afterwards.